Literature DB >> 20193960

Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP.

Anna Maria Lombardi, Giulia Berti de Marinis, Raffaella Scandellari, Francesca Magalini, Paolo Sansoni, Pier Ferruccio Ballerini, Silvia Vettore, Nicole Candeo, Piero Marson, Giustina De Silvestro, Fabrizio Fabris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193960     DOI: 10.1016/j.thromres.2010.02.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

Review 1.  Rituximab in immunologic glomerular diseases.

Authors:  A Ahsan Ejaz; Abdo Asmar; Mourad M Alsabbagh; Nasimul Ahsan
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

Review 2.  Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors:  Nay M Tun; Gina M Villani
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.